+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Europe Equine Healthcare Market Size, Share & Trends Analysis Report by Product (Pharmaceuticals, Vaccine), Indication (West Nile Virus, Tetanus), Activity (Sports/Racing, Recreation), Distribution Channel, and Country with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 180 Pages
  • September 2025
  • Region: Europe
  • Grand View Research
  • ID: 5976580
The Europe equine healthcare market size was estimated at USD 1.05 Billion in 2025 and is projected to reach USD 1.90 billion by 2033, growing at a CAGR of 7.57% from 2025 to 2033. The market is witnessing growth driven by the growing equine population and economic value, rising veterinarian guidance for preventive care, and increasing adoption of insurance and welfare programs.

The growing equine population within countries such as Germany, France, and the UK is creating opportunities for advanced veterinary care for the development of pharmaceuticals, vaccines, diagnostics, or services. According to the European Commission report, the equine population in the European Union (EU) is estimated to be approximately 6 million, with 429,800 horses in the UK. This rising equine population is driving significant growth opportunities in Europe’s equine healthcare market, fostering innovation across pharmaceuticals, vaccines, diagnostics, and veterinary services.

Some of the countries in Europe, such as the UK, France, and Ireland, are continuously involved in horse breeding and recreational or sports activities. Hence, horses are of great economic value in the category of companion animals. Their high economic importance drives the market for larger investment in veterinary care, advanced therapeutics, and specialized hospital services. For instance, in March 2024, Scandinavian ChemoTech’s Animal Care secured a USD 52k order from Europe’s leading equine clinic, EquiTom (Belgium), adopting vetIQure TSE technology after successful sarcoid treatments, enhancing innovation and patient outcomes in equine healthcare. As a result, the need for efficient healthcare solutions, including pharmaceuticals, vaccines, diagnostic tools, and reproductive management products, continues to expand across European equine markets.

Rising veterinarian guidance for preventive care is one of the drivers of the European equine healthcare market. With increasing awareness of equine welfare, veterinarians are emphasizing regular check-ups, vaccinations, deworming, and nutritional management to reduce the incidence of costly diseases. Preventive protocols help owners maintain peak equine performance, minimize risks of infectious outbreaks, and improve long-term health outcomes. In Europe, structured veterinary programs and educational campaigns encourage horse owners to adopt proactive healthcare measures rather than reactive treatment. For instance, in November 2022, British Equestrian launched Equine Health Week with vet-led education, daily disease awareness and the release of new EIDAG (Equine Infectious Diseases Advisory Group) guidance to reduce equine infectious disease risks. In addition, in March 2023, CANTER, launched to combat equine antiparasitic resistance, uniting veterinarians, pharmaceutical companies, diagnostic providers, and policymakers to promote sustainable parasite control and safeguard horse health and welfare. This shift enhances animal well-being and fuels demand for vaccines, supplements, and diagnostic services, boosting the industry.

Europe Equine Healthcare Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Europe equine healthcare market report based on product, indication, activity, distribution channel, and country:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceuticals
  • Vaccines
  • Medicinal Feed Additives
  • Orthobiologics
  • Diagnostics
  • Software & Services
  • Others

Indication Outlook (Revenue, USD Million, 2021-2033)

  • Musculoskeletal Disorders
  • Parasitic Infections
  • Equine Herpes Virus
  • Equine Viral Arteritis (EVA)
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Other Indications

Activity Outlook (Revenue, USD Million, 2021-2033)

  • Sports/ Racing
  • Recreation
  • Other Activities

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Equestrian Facilities
  • Other Channels

Country Outlook (Revenue, USD Million, 2021-2033)

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
  • Netherlands
  • Russia
  • Switzerland

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Indication
1.2.3. Activity
1.2.4. Distribution Channel
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information/Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Model 1 Analysis
1.7.2. Model 2 Analysis
1.7.3. Model 3 Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary/Related Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Equine Population and Economic Value
3.2.1.2. Rising Veterinarian Guidance for Preventive Care
3.2.1.3. Increasing Adoption of Insurance and Welfare Programs
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Advanced Equine Healthcare Solutions
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Estimated Equine Population by country, 2024
3.6. Market Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL by SWOT Analysis
Chapter 4. Europe Equine Healthcare Market: Product Estimates & Trend Analysis
4.1. Europe Equine Healthcare Market, by Product: Segment Dashboard
4.2. Europe Equine Healthcare Market, by Product Movement Analysis
4.3. Europe Equine Healthcare Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
4.4. Pharmaceuticals
4.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021-2033(USD Million)
4.4.2. Parasiticides
4.4.2.1. Parasiticides Market Estimates and Forecasts, 2021-2033(USD Million)
4.4.3. Anti-infectives
4.4.3.1. Anti-infectives Market Estimates and Forecasts, 2021-2033(USD Million)
4.4.4. Anti-inflammatory & Analgesics
4.4.4.1. Anti-inflammatory & Analgesics Market Estimates and Forecasts, 2021-2033(USD Million)
4.4.5. Other Pharmaceuticals
4.4.5.1. Other Pharmaceuticals Market Estimates and Forecasts, 2021-2033(USD Million)
4.5. Vaccines
4.5.1. Vaccines Market Estimates and Forecasts, 2021-2033(USD Million)
4.6. Medicinal Feed Additives
4.6.1. Medicinal Feed Additives Market Estimates and Forecasts, 2021-2033(USD Million)
4.7. Orthobiologics
4.7.1. Orthobiologics Market Estimates and Forecasts, 2021-2033(USD Million)
4.8. Diagnostics
4.8.1. Diagnostics Market Estimates and Forecasts, 2021-2033(USD Million)
4.8.2. Diagnostic Test Kits
4.8.2.1. Diagnostic Test Kits Market Estimates and Forecasts, 2021-2033(USD Million)
4.8.3. Diagnostics Equipments
4.8.3.1. Diagnostics Equipments Market Estimates and Forecasts, 2021-2033(USD Million)
4.9. Software & Services
4.9.1. Software & Services Market Estimates and Forecasts, 2021-2033(USD Million)
4.9.2. Practice Management Software
4.9.2.1. Practice Management Software Market Estimates and Forecasts, 2021-2033(USD Million)
4.9.3. Imaging Software
4.9.3.1. Imaging Software Market Estimates and Forecasts, 2021-2033(USD Million)
4.9.4. Telehealth Software
4.9.4.1. Telehealth Software Market Estimates and Forecasts, 2021-2033(USD Million)
4.9.5. Other Software & Services
4.9.5.1. Other Software & Services Market Estimates and Forecasts, 2021-2033(USD Million)
4.10. Others
4.10.1. Others Market Estimates and Forecasts, 2021-2033(USD Million)
Chapter 5. Europe Equine Healthcare Market: Indication Estimates & Trend Analysis
5.1. Europe Equine Healthcare Market, by Indication: Segment Dashboard
5.2. Europe Equine Healthcare Market, by Indication Movement Analysis
5.3. Europe Equine Healthcare Market Estimates & Forecasts, by Indication, 2021 to 2033 (USD Million)
5.4. Musculoskeletal Disorders
5.4.1. Musculoskeletal Disorders Market Estimates and Forecasts, 2021-2033(USD Million)
5.5. Parasitic Infections
5.5.1. Parasitic Infections Market Estimates and Forecasts, 2021-2033(USD Million)
5.6. Equine Herpes Virus
5.6.1. Equine Herpes Virus Market Estimates and Forecasts, 2021-2033(USD Million)
5.7. Equine Viral Arteritis (EVA)
5.7.1. Equine Viral Arteritis (EVA) Market Estimates and Forecasts, 2021-2033(USD Million)
5.8. Equine Influenza
5.8.1. Equine Influenza Market Estimates and Forecasts, 2021-2033(USD Million)
5.9. West Nile Virus
5.9.1. West Nile Virus Market Estimates and Forecasts, 2021-2033(USD Million)
5.10. Tetanus
5.10.1. Tetanus Market Estimates and Forecasts, 2021-2033(USD Million)
5.11. Other Indications
5.11.1. Other Indications Market Estimates and Forecasts, 2021-2033(USD Million)
Chapter 6. Europe Equine Healthcare Market: by Activity Estimates & Trend Analysis
6.1. Europe Equine Healthcare Market, by Activity: Segment Dashboard
6.2. Europe Equine Healthcare Market, by Activity Movement Analysis
6.3. Europe Equine Healthcare Market Estimates & Forecasts, by Activity, 2021 to 2033 (USD Million)
6.3.1. Sports/ Racing
6.3.1.1. Sports/ Racing Market Estimates and Forecasts, 2021-2033(USD Million)
6.3.2. Recreation
6.3.2.1. Recreation Market Estimates and Forecasts, 2021-2033(USD Million)
6.3.3. Others
6.3.3.1. Others Market Estimates and Forecasts, 2021-2033(USD Million)
Chapter 7. Europe Equine Healthcare Market: by Distribution Channel Estimates & Trend Analysis
7.1. Europe Equine Healthcare Market, by Distribution Channel: Segment Dashboard
7.2. Europe Equine Healthcare Market, by Distribution Channel Movement Analysis
7.3. Europe Equine Healthcare Market Estimates & Forecasts, by Distribution Channel, 2021 to 2033 (USD Million)
7.3.1. Veterinary Hospitals & Clinics
7.3.1.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021-2033(USD Million)
7.3.2. E-commerce
7.3.2.1. E-commerce Market Estimates and Forecasts, 2021-2033(USD Million)
7.3.3. Equestrian Facilities
7.3.3.1. Equestrian Facilities Market Estimates and Forecasts, 2021-2033(USD Million)
7.3.4. Others
7.3.4.1. Others Market Estimates and Forecasts, 2021-2033(USD Million)
Chapter 8. Europe Equine Healthcare Market: by Country Estimates & Trend Analysis
8.1. Country Market Dashboard
8.2. Country Market Share Analysis, 2024 & 2033
8.3. Europe
8.3.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. UK Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.10. Netherlands
8.3.10.1. Key Country Dynamics
8.3.10.2. Competitive Scenario
8.3.10.3. Regulatory Framework
8.3.10.4. Netherlands Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.11. Russia
8.3.11.1. Key Country Dynamics
8.3.11.2. Competitive Scenario
8.3.11.3. Regulatory Framework
8.3.11.4. Russia Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.12. Switzerland
8.3.12.1. Key Country Dynamics
8.3.12.2. Competitive Scenario
8.3.12.3. Regulatory Framework
8.3.12.4. Switzerland Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
9.3. Company Profiles
9.3.1. Boehringer Ingelheim International GmbH.
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product/Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Dechra
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product/Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Ceva Sante Animale
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product/Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Esaote S.p.A
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product/Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. AVANTEA
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product/Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Equistro
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product/Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Intervacc
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product/Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. HIPRA
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product/Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Hallmarq Veterinary Imaging
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product/Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Virbac
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product/Service Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Norbrook
9.3.11.1. Participant’s Overview
9.3.11.2. Financial Performance
9.3.11.3. Product/Service Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. Strategy Mapping
9.3.13. Mergers & Acquisitions
9.3.14. Partnerships & Collaborations
9.3.15. Product launch
9.3.16. Others
9.4. List of other key players
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Europe Equine Healthcare Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 4 Europe Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 5 Europe Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 6 Europe Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 7 Europe Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 8 Germany Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 9 Germany Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 10 Germany Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 11 Germany Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 12 UK Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 13 UK Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 14 UK Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 15 UK Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 16 France Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 17 France Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 18 France Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 19 France Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 20 Italy Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 21 Italy Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 22 Italy Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 23 Italy Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 24 Spain Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 25 Spain Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 26 Spain Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 27 Spain Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 28 Denmark Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 29 Denmark Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 30 Denmark Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 31 Denmark Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 32 Sweden Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 33 Sweden Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 34 Sweden Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 35 Sweden Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 36 Norway Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 37 Norway Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 38 Norway Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 39 Norway Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 40 Netherlands Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 41 Netherlands Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 42 Netherlands Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 43 Netherlands Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 44 Russia Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 45 Russia Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 46 Russia Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 47 Russia Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
Table 48 Switzerland Equine Healthcare Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 49 Switzerland Equine Healthcare Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 50 Switzerland Equine Healthcare Market Estimates and Forecasts, by Activity, 2021-2033 (USD Million)
Table 51 Switzerland Equine Healthcare Market Estimates and Forecasts, by Distribution Channel, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Market Formulation & Validation
Figure 6 Commodity Flow Analysis
Figure 7 Value Chain-Based Sizing & Forecasting
Figure 8 QFD Model Sizing & Forecasting
Figure 9 Bottom-Up Approach
Figure 10 Market Snapshot
Figure 11 Segment Snapshot 1
Figure 12 Segment Snapshot 2
Figure 13 Competitive Landscape Snapshot
Figure 14 Parent Market Outlook, 2024 (USD Billion)
Figure 15 Ancillary Market Outlook, 2024 (USD Billion)
Figure 16 Europe Equine Healthcare Market Dynamics
Figure 17 Porter’s Five Forces Analysis
Figure 18 PESTEL Analysis
Figure 19 Europe Equine Healthcare Market: Product Outlook And Key Takeaways
Figure 20 Europe Equine Healthcare Market: Product Movement Analysis
Figure 21 Pharmaceuticals Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 22 Parasiticides Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 23 Anti-infectives Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 24 Anti-inflammatory & Analgesics Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 25 Other Pharmaceuticals Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 26 Vaccines Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 27 Medicinal Feed Additives Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 28 Orthobiologics Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 29 Diagnostics Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 30 Diagnostic Test Kits Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 31 Diagnostics Equipments Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 32 Software & Services Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 33 Practice Management Software Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 34 Imaging Software Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 35 Telehealth Software Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 36 Other Software & Services Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 37 Others Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 38 Europe Equine Healthcare Market: Indication Outlook And Key Takeaways
Figure 39 Europe Equine Healthcare Market: Indication Movement Analysis
Figure 40 Musculoskeletal Disorders Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 41 Parasitic Infections Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 42 Equine Herpes Virus Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 43 Equine Viral Arteritis (EVA) Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 44 Equine Influenza Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 45 West Nile Virus Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 46 Tetanus Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 47 Others Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 48 Europe Equine Healthcare Market: Activity Outlook And Key Takeaways
Figure 49 Europe Equine Healthcare Market: Activity Movement Analysis
Figure 50 Sports/ Racing Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 51 Recreation Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 52 Others Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 53 Europe Equine Healthcare Market: Distribution Channel Outlook And Key Takeaways
Figure 54 Europe Equine Healthcare Market: Distribution Channel Movement Analysis
Figure 55 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 56 E-Commerce Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 57 Equestrian Facilities Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 58 Others Market Estimates And Forecasts, 2021-2033 (USD Million)
Figure 59 Country Marketplace: Key Takeaways
Figure 60 Europe Equine Healthcare Market, 2021-2033 (USD Million)
Figure 61 Key Country Dynamics
Figure 62 UK Equine Healthcare Market, 2021-2033 (USD Million)
Figure 63 Key Country Dynamics
Figure 64 Germany Equine Healthcare Market, 2021-2033 (USD Million)
Figure 65 Key Country Dynamics
Figure 66 France Equine Healthcare Market, 2021-2033 (USD Million)
Figure 67 Key Country Dynamics
Figure 68 Italy Equine Healthcare Market, 2021-2033 (USD Million)
Figure 69 Key Country Dynamics
Figure 70 Spain Equine Healthcare Market, 2021-2033 (USD Million)
Figure 71 Key Country Dynamics
Figure 72 Denmark Equine Healthcare Market, 2021-2033 (USD Million)
Figure 73 Key Country Dynamics
Figure 74 Sweden Equine Healthcare Market, 2021-2033 (USD Million)
Figure 75 Key Country Dynamics
Figure 76 Norway Equine Healthcare Market, 2021-2033 (USD Million)
Figure 77 Key Country Dynamics
Figure 78 Netherlands
Figure 79 Key Country Dynamics
Figure 80 Russia
Figure 81 Key Country Dynamics
Figure 82 Switzerland
Figure 83 Key Country Dynamics
Figure 84 Key Company Categorization
Figure 85 Heat Map Analysis
Figure 86 Strategic Framework

Companies Mentioned

The leading players profiled in this Europe Equine Healthcare market report include:
  • Dechra
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Esaote SPA
  • AVANTEA
  • Intervacc
  • HIPRA
  • Equistro
  • Hallmarq Veterinary Imaging
  • Virbac
  • Norbrook

Table Information